Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models
Double-Cross Research Models

Updated 3 November 2010

back to Research Models Index

Viewing tips: Make your browser window wide enough to view the table, which should fit on most standard monitors. 

 
Name/Symbol Strain Name Transgene/
Promoter and Regulatory Elements
Genetic Background Behavioral 
Phenotype
Neurological 
Characteristics
Patents/
Availability
Primary Citation
APPSwDI/NOS2-/-

Symbol: APP/Nos ko

Updated 5/18/09
B6.Cg-Nos2tm1Lau Tg(Thy1-APPSwDutIowa)BWevn/J Homozygous Tg(Thy1-APPSwDutIowa)BWevn females (Stock #007027) bred with heterozygous or homozygous Nos2tm1Lau males (Stock #002609). Donor strain: 129P2 via E14TG2a ES cell line. Background: C57BL/6. Severe learning and memory deficits. Mice progress from Aβ production and amyloid deposition to hyperphosphorylated normal mouse tau, aggregation and redistribution of tau to somatodendritic regions of neurons, significant neuronal loss (including loss of interneurons), moderate-severe cerebral amyloid angiopathy. The Jackson Lab, under development, stock #009126. For research or non-commercial use only. Colton et al., 2008
APPSwe (line C3-3)/PS1deltaE9 (line S-9)

Symbol: APP/PS1dE9

Posted 12/29/08
B6.Cg-Tg(APP695)3Dbo Tg(PSEN1dE9)S9Dbo/J APPSwe (line C3-3) crossed with PS1deltaE9 (line S-9). Origin: (C57BL/6J x C3H/HeJ)F2, Congenic, Generation: [N7p]+N4F3 (19-Dec-08). Double tg mice are viable and fertile. Amyloid plaque deposition at 6 months. At 18 months, amyloid deposits increased with significant but mild decreases in cholinergic markers (cortex and hippocampus) and somatostatin levels (cortex). Older double tg mice impaired in all cognitive tasks, and deficits in episodic-like memory tasks correlate with total amyloid-beta peptide loads in the brain. The Jackson Lab, available, stock #005866. For research or non-commercial use only. Savonenko et al., 2005
rTg(tauP301L) 4510

Symbol: Tau

Posted 12/10/05
  Mice expressing activator transgenes tet-off ORF downsteam of Ca2+ calmodulin kinase II promoter/Mice expressing responder transgene, TRE upstream of 4R0N tauP301L mutation. Origin: Activator transgene mice on 129S6, backcross 5x. Responder transgene mice (Tau P301L) on FVB/N. Spatial defects, cognitive impairments early. At 9.5 months exhibit decreased ambulation, body wt, hunched posture but continue to live, now >20 months. Progressive age-related NFTs, and neuronal loss and severe forebrain atrophy. Tau mRNA restricted to forebrain (neuronal cell types). With doxycycline treatment, memory function recovered, neuron numbers stabilized, but NFTs continued to accumulate. Contact Dr. Susan Stoddard
Mayo Medical Ventures, Rochester, MN
SantaCruz et al., 2005
Tet/GSK3β/Tauvlw

Symbol: GSK3β/Tau

Posted 10/30/2005

  Crossed Tet/GSK3β with Tauvlw/CamKIIa and Thy1.2 Origin: C57Bl6j x CBA Mice are viable and fertile Mice show tau hyperphosphorylation in hippocampal neurons, with thioflavin-S staining and formation of >10nm filaments. Atrophy seen in Tet/GSK-3β mice develops faster in these Tet/ GSK-3β/Tauvlw mice. European Patent Application No 01936609.5. Title, Model for neurodegenerative disease; Inventors: JJ Lucas, F Hernandez, J Avila; Contact Jesús Avila
or Felix Hernandez
Engel et al., 2005
Tet/GSK3β

Symbol: GSK3β

Posted 10/30/2005

  Tet/GSK-3ß mice were generated by crossing mice expressing tTA under control of the CamKIIa promoter (tTA) with mice that have incorporated the BitetO construct in their genome (TetO). The double transgenic progeny (Tet/GSK-3ß) express GSK-3β constitutively in the brain. Origin: CBAxC57BL/6 Mice are viable and fertile Overexpression of GSK-3β results in neurodegeneration such as β-catenin destabilization and pretangle-like somatodendritic localization of hyperphosphorylated tau. Highest level of transgenic GSK-3β expression is in the hippocampus, then cortex. European Patent Application No 01936609.5. Title, Model for neurodegenerative disease; Inventors: JJ Lucas, F Hernandez, J Avila; Contact Jesús Avila Lucas et al., 2001
APPswe/Tauvlw

Symbol: APP/Tau

Posted 10/30/2005

  Crossed APPSwe (Tg2576) and Tauvlw Origin: C57Bl6j x CBA x SJL At 16 months single APPSwe and double tg mice have increased spatial memory impairment compared to single Tauvlw Double tg mice showed enhanced amyloid deposition accompanied by neurofibrillary degeneration and overt neuronal loss in selectively vulnerable brain areas. European Patent Application No 01936609.5. Title, Model for neurodegenerative disease; Inventors: JJ Lucas, F Hernandez, J Avila; Contact Jesús Avila Perez et al., 2005
GSK3βS9A/Tau4R

Symbol: GSK3βS9A/Tau

Posted 8/27/2005

  Crossed GSK3βS9A with Tau4R Origin: FVB/N (Crl)   Expression in neurons, high level in cortex and hippocampus. Hyperphosphorylation of tau at 4-6 weeks, no insoluble tau aggregates or tangles. Rescue of tau axonopathy of tau 4R. Contact Paul Van Dun Spittaels et al., 2000
APPLo/PS1A246E

Symbol: APP/PS1

Posted 7/26/2005

  Crossed APPV717I (London) with PS1A246E Origin: FVB/N (Crl)   Both transgenes co-expressed in neurons only. Mice at 6-9 months have increased Aβ levels with amyloid plaques and CAA. Contact Paul Van Dun Dewachter et al., 2000
APPLo/PS1(n-/-)

Symbol: APP/PS1

Posted 7/26/2005

  Crossed APP(London) with PS1 (n-/-). Origin: FVB/N (Crl)   In bigenic mice the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old. LTP also was rescued in bigenic mice but not the cognitive defect of APP(V717I) mice. Contact Paul Van Dun Dewachter et al., 2002
BACE x APP(V717I)

Symbol: BACE/APP

Posted 6/10/2005

  Crossed BACE-1 (Line 16) (Willem) with APP(V717I)/mutation hBACE and APP London/mouse Thy 1 Origin: Offspring are double tg that are heterozygous for both transgenes and with identical FVB/C57BL background.   Amyloidogenic processing is increased at Asp1 and Glu11 resulting in more Aβ peptides in bigenic brains. In older bigenic mice BACE1 increased the number of diffuse and senile amyloid plaques. Vascular amyloid deposition was reduced compared single APPV717I mice. Contact Paul Van Dun Willem et al., 2004
APP/ADAM10 OE

Symbol: APP/ADAM

Posted 6/10/2005

  APPV717I were intercrossed with ADAM10 Origin: FVB/N Improved Morris Water Maze test compared to APPV717I mice. Bigenic mice showed increased secretion of the neurotrophic soluble α-secretase-released N-terminal APP domain (APPsα), reduced formation of Aβ peptides, and prevented their deposition in plaques. Functionally, impaired long-term potentiation and cognitive deficits were alleviated. Not available.
Contact Falk Fahrenholz
Fax 49-6131-392-5348
Postina et al., 2004
APP/ADAM10 dn (catalytically inactive mutant)

Symbol: APP/ADAM

Posted 6/10/2005

  APPV717I were intercrossed with ADAM10 dn Origin: FVB/N Improved Morris Water Maze test compared to APPV717I mice. Expression of ADAM10dn led to an enhancement of the number and size of amyloid plaques in the brains of double-transgenic mice. Not available.
Contact Falk Fahrenholz
Fax 49-6131-392-5348
Postina et al., 2004
PS2N141I/APPSwe

Symbol: PS2-APP

Posted 6/9/2005

  Crossed male APPSwe (AD147.71H) with female PS2N141I (Prp-huPS2.30H). Murine prion protein genomic fragment (pPrnpHG) was used for PS2 and mThy-1.2 for APPSwe Origin: C57BL/6 x DBA/2. Behavioral changes begin when Aβ deposits and inflammation appear in the subiculum and frontolateral cortex. At 8 months, age-related cognitive deficits and amyloid deposits with inflammation in neo-and limbic cortices. Metabolic profile at 20 months indicates hypometabolism. Contact: Laurence Ozmen
Laurence.ozmen@roche.com
Richards et al., 2003
APP/RAGE

Symbol: RAGE

Posted 4/1/2005

  hRAGE (see Yan wt hRAGE) crossed with mAPPSwInd (see TJL #004661) C57BL/6J, generation >N10   Earlier abnormalities in spatial learning/memory, accompanied by altered activation of markers of synaptic plasticity and exaggerated neuropathologic findings than in single tg mice. Contact: Shi Du Yan,
sdy1@columbia.edu
Arancio et al., 2004
APP/DN-RAGE

Symbol: RAGE

Posted 4/1/2005

  Full-length dominate negative hRAGE /PDGF-ß promoter/6apc1 vector/microinjected into B6CBAF1/J oocytes/ crossed with mAPP (see TJL #004661) C57BL/6J, generation >N10 Normal reproduction and performance Tg APP/dnRAGE animals displayed preservation of spatial learning/memory and diminished neuropathologic changes. Contact: Shi Du Yan,
sdy1@columbia.edu
Arancio et al., 2004
APPSw/hBACE

Symbol: APP/BACE

Posted 3/6/2005

  Crossed APPSw(KM670/671NL)(Tac #001349) and hBACE (Lee) Bigenic mice C57BL/6/C3H/SJL N/A High BACE overexpression inhibited amyloid formation despite increased β-cleavage of APP, and shifted the subcellular location of APP cleavage to the neuronal perikarya early in the secretory pathway thereby depleting APP destined for axonal transport. Contact: Virginia M-Y Lee
vmylee@mail.med.upenn.edu
Lee et al., 2005
APP751SL/PS1 KI

Symbol:APP/PS1

Updated 5/22/2005
  PS1(M233T) (L235P) and APP751 London (V717I), Swedish (K670N/M671L)/Thy1 Origin: C57BL/6 Viable and fertile animals Mice show acceleration of Aβ peptide deposition and develop age-dependent massive neuronal loss in hippocampus (CA1/2 subfield). Strong Aβ immunostaining and accumulation of thioflavine-S-positive stain in pyramidal cell layer precede neuronal loss. Strong astrogliosis occurrs near Aβ-positive neurons. Laurent Pradier Casas et al., 2004
cPS1 conditional Double Ko (cDKo)

Symbol: PS1

Posted 7/10/04

  Crossed floxed PS1 (fPS1), αCaMKII-Cre transgenic mice and PS2-/- mice together to obtain fPS1/fPS1;αCaMKII-Cre;PS2-/- mice. Origin: C57BL6/129 hybrid Viable, no difference from controls. No alterations in behavior, motor coordination or exploratory anxiety. Mice lacking both presenilins in forebrain exhibit impairments in memory and synaptic plasticity. With age they develop neurodegeneration of cerebral cortex and worsening memory and synaptic function with an increase in p25 and hyperphosphorylated tau. Contact Jie Shen
jshen@rics.bwh.harvard.edu
Saura et al., 2004
MAPT Mapt GFP
(See JAX datasheet)

Updated 1/18/05

STOCK Mapttm1(GFP)Klt Tg(MAPT)8cPdav/J Double mutant mice were generated by crossing hTau transgenic mice (mouse line 8C) with Mapt targeted mutant mice (Mapt exon disrupted, replaced with EGFP fused to the first 31 MAPT aa. Targeted allele = J1 ES cell then C57BL/6 blastocysts, homozygous. Transgenic allele= Swiss Webster/ B6D2F1, hemizygous Mice are viable and fertile. No endogenous mouse Tau, six isoforms of hTau expressed. Hyperphosphorylated tau detected in cell bodies and dendrites. Paired helical filaments of aggregated insoluble Tau isolated from brain at 2 months. Available
The Jackson Lab: Stock #004808
Andorfer et al., 2003
PS-1(P264L)/APPswe

Symbol: PS-1/APP

Posted 1/23/04
  PS-1 (P264L) mice cross-bred with APP695Swe (Tg2576) or APPsweKI     Cultured neurons have increased Aβ42 and reduced Aβ40. PS-1 mutation increases Aβ42 levels and accelerates amyloid deposits and gliosis. Contact Dorothy Flood at dflood@cephalon.com or Steve Trusko strusko@cephalon.com at Cephalon Siman et al., 2000.
APPswe/PS1(A246E)

Symbol: APP695; Psen1
(See JAX datasheet)

Updated 12/29/08

B6C3-Tg(APP695)3Dbo Tg(PSEN1)5Dbo/J Psen-1 tg: hPsen-1 (A246E substitution) (line N-5)/Prnp/B6C3H pronuclei. APP tg: StrainC3B6-Tg(APP695)3Dbo (founder line C3-3) (TJL 003375). Psen-1(A246E) crossed with APPSwe = double trangenic Origin:B6;C3H. Mated double transgenics to C3B6F1 mice. Mice are hemizygous (only 1 in 4 pups is a double transgenic). Generation: F2N2+N1p.   Elevated levels of the Aβ1-42(43) peptide detected in mouse brain homogenates. By 9 months of age, numerous amyloid deposits detected and they increase dramatically between the ages of 10 and 12 months. Available
The Jackson Lab, cryopreserved, stock #003378. For research or non-commercial use only.
Borchelt et al, 1997
Mo/Hu APPswe PS1dE9

Symbol: APP695; PSEN1;
(See JAX datasheet)

Updated 12/11/08

B6C3-Tg(APPswe, PSEN1dE9)85Dbo/J B6C3HF2 pronuclei coinjected with hPsen-1 and APP695/MoPrnp B6C3F1/J background. Cross tg +/+ sibling to Hemizygote. BackcrossG1. Generation: N1F10 (20-DEC-06). Exhibit selective spatial deficit in Morris WM and disinhibitory tendencies in elevated plus maze (Lalond et al., Neurosci Lett 2005) Develop β-amyloid deposits in the brains of transgenic animals by 6 to 7 months of age. APP and PSEN1 are immunodetected in whole brain protein homogenates. The Jackson Lab, currently on HOLD, Stock 004462. For research or non-commercial use only. Jankowsky et al, 2001
Mo/Hu APPswe PS1dE9

Symbol: APP695; PSEN1;
(See JAX datasheet)

Posted 12/11/08

B6Cg-Tg(APPswe, PSEN1dE9)85Dbo/J B6C3HF2 pronuclei coinjected with hPsen-1 and huAPP695/MoPrnp Origin: (C57BL/6 x C3H)F2, Backcrossed to C57BL/6J, Congenic, Generation: N8?+N3 (20-DEC-07). Exhibit selective spatial deficit in Morris WM and disinhibitory tendencies in elevated plus maze (Lalond et al., Neurosci Lett 2005) Develop β-amyloid deposits in the brains of transgenic animals by 6 to 7 months of age. APP and PSEN1 are immunodetected in whole brain protein homogenates. The Jackson Lab, available, stock # 005864. For research or non-commercial use only. Jankowsky et al., 2001
3-Repeat Tau + PSI M146L   Tg expressing 3-repeat human tau isoform, without the N-terminal insert, under the control of a modified promoter of the 3-hydroxy-methyl-glutaryl coenzyme. PS1Tg generated using human mutated PS1M146L under the control of the same promoter. Doubly transgenic mice for human tau and human mutated PS1M146L were generated by cross-breeding of single transgenic mice.     Increased expression of the PS1 holoprotein was observed. Proteolytic fragments of PS1 did not appear to be modified. A somatodendritic accumulation of the transgenic tau and an increase in tau phosphorylation in both tau- and tau/PS1 Tgs. Neurofibrillary tangles were not observed in animals analyzed up to 17 months. Contact J.P. Brion
jpbrion@ulb.ac.be
Boutajangout et al. Neuroscience Letters 318 (2002) 29–33
APPSwe 2576/Tau JNPL3

Symbol: APP/Tau

Updated 11/1/10

STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc P301L 4 repeat Tau (JNPL3) x Appswe (Tg2576) Origin: Crossed homozygous female Tau (Tac #2508M) with hemizygous male APP2576 (Tac #1349T). Developed motor disturbances similar to JNPL3, with identical range in age of onset, including progressive hindlimb weakness, hunched posture, eye irritations, reduced vocalization, and decreased grooming. Developed Aβ deposits at the same age as Tg2576; exhibited neurofibrillary tangle pathology that was substantially enhanced in the limbic system and olfactory cortex. Available: Model #002469.
Control Model #003273 For research purposes only. For breeding must have a Research Crossbreeding Agreement with Taconic. No distribution to third parties.
Lewis et al., 2001.
APPV717/ ApoE-/-     (Swiss Webster X C57BL/6 X DBA/2) X C57BL/6   fibrillar Ab deposits and neuritic plaques by 15 months of age and substantially (>10-fold) more fibrillar deposits were observed in apoE4-expressing APPV717F TG mice.   Holtzman
APP + Alpha Synuclein   Heterozygous hSYN mice from line D were crossed with heterozygous hAPP mice from line J9         Masliah et al, 2001

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad